Woodward, Alexander
Hashikawa, Tsutomu
Maeda, Masahide
Kaneko, Takaaki
Hikishima, Keigo
Iriki, Atsushi
Okano, Hideyuki
Yamaguchi, Yoko
Article History
Received: 16 August 2017
Accepted: 18 December 2017
First Online: 13 February 2018
Change Date: 18 March 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41597-022-01247-z
Competing interests
: A.I. is the President and CEO of Rikaenalysis Corporation (RIKEN Venture, Tokyo). H.O. is a paid Scientific Advisory Board of SanBio Co Ltd and K Pharma Inc. The other authors declare no competing financial interests.